Target intelligence / Profile preview

novel transcript, antisense to Defensin alpha 4 (ENSG00000295941)

Target: ENSG00000295941
Molecular classification: Other

Overview

This designation refers to a novel transcript annotated on the antisense strand of the DEFA4 gene locus; it is not the canonical Defensin alpha 4 gene or protein. There is insufficient published evidence that it is a validated protein-coding or functional noncoding RNA. No associations with biological function, disease, pharmacology, or protein family classification have been established for this transcript, and it is not considered a therapeutic target or biomarker at this time[3].

Other names: ENSG00000295941antisense DEFA4 transcript

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on novel transcript, antisense to Defensin alpha 4 (ENSG00000295941).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to Defensin alpha 4 (ENSG00000295941).

Explore the full profile